Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.
But at least two of those drugs, sourced by the Delhi government’s central procurement agency, were procured in an alleged violation of norms as their manufacturers had been blacklisted after their other medicines failed lab tests in several states, Newslaundry has found.
